COMMUNIQUÉS West-GlobeNewswire

ObsEva SA Announces $60.0 Million Private Placement with Existing and New Investors
10/10/2017
Geneva, Switzerland and Boston, MA - 10 October, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
The IPO of Terveystalo Plc has been oversubscribed and the listing will be completed as planned
10/10/2017
TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 10, 2017 at 3:00 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections
10/10/2017
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections LONDON, 10 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a [...]
Apricus Biosciences to Present at the 2017 BIO Investor Forum
10/10/2017
SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief [...]
ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
10/10/2017
Amsterdam, The Netherlands - 10 October 2017 As of today, EUR 2,700,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 112,500 of warrants out of a total [...]
Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO)
10/10/2017
Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO) Lugano, Switzerland, [...]
Solon Eiendom ASA : Primary insider notification
10/10/2017
(Oslo, Norway, 09 October 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 18,306 shares in Solon Eiendom ASA at a price of NOK 18.7198 per [...]
Immunicum AB (publ) Announces Appointment of Sharon Longhurst as Head of CMC
10/10/2017
Press Release 10 October 2017 Immunicum AB (publ) Announces Appointment of Sharon Longhurst as Head of CMC Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming [...]
Akcea Therapeutics' Volanesorsen Receives Promising Innovative Medicine (PIM) Status for the Treatment of Familial Chylomicronaemia Syndrome (FCS)
10/10/2017
LONDON, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics United Kingdom (UK) today announced that volanesorsen has been granted a Promising Innovative Medicine (PIM) Designation by the Medicines and Healthcare [...]
Nicox et pSivida : accord de collaboration stratégique en vue du développement d'un médicament à libération prolongée pour réduire la pression intraoculaire chez les patients atteints de glaucome
10/10/2017
Communiqué de presse Nicox et pSivida : accord de collaboration stratégique en vue du développement d'un médicament à libération prolongée pour réduire la pression intraoculaire chez les patients atteints de glaucome [...]
Nicox and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular pressure in patients with glaucoma
10/10/2017
Press Release Nicox and pSivida Enter Strategic Collaboration Agreement to Develop Sustained Release Drug to Lower Intraocular Pressure in Patients with Glaucoma Focus will be on Combining Nicox's New Nitric Oxide [...]
MITHRA'S MARKETING AUTHORIZATION APPLICATION FOR TIBELIA® ACCEPTED BY HEALTH CANADA
10/10/2017
PRESS RELEASE MIThRA'S MARKETING AUTHORIZATION APPLICATION FOR TiBELIA® ACCEPTED BY HEALTH CANADA Tibelia® would be the first tibolone-based Hormone Therapy product available in Canada Marketing Authorization (MA) [...]
ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
10/10/2017
Amsterdam, The Netherlands - 10 October 2017 As of today, EUR 2,700,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 112,500 of warrants out of a total [...]
Biocartis Group NV: Disclosure of outstanding voting securities
10/10/2017
PRESS RELEASE: REGULATED INFORMATION 10 October 2017, 07:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 10 October 2017 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
Medtronic to Establish Innovation Center in Chengdu
10/10/2017
Facilitating Clinical Training for Physicians and Advancing Local Healthcare Efficiency in Central and Western China DUBLIN and CHENGDU, Sichuan - October 10, 2017 - Medtronic plc (NYSE:MDT) today announced the [...]
IBA SA : IBA signe un accord de collaboration mondial avec VINCI Construction
10/10/2017
IBA signe un accord de collaboration mondial avec VINCI Construction Nouvelle collaboration afin de fournir un soutien de conception et de construction de centres de protonthérapie spécifiquement destiné aux clients d' [...]
IBA SA : IBA signs global construction collaboration with VINCI Construction
10/10/2017
IBA signs global construction collaboration with VINCI Construction New collaboration to provide dedicated proton therapy center design and construction support for customers Louvain-La-Neuve, Belgium, 10 October 2017 [...]
Xbrane Biopharma AB appoints Dina Jurman, Head of Clinical Affairs, to management team
09/10/2017
Press release 2017-10-09 Xbrane Biopharma AB (publ) has appointed Dina Jurman, Head of Clinical Affairs at Xbrane, to its management team. Dina holds a M.Sc. in Biomedicine from Uppsala University and has previously [...]
CORRECTION: Össur hf: Q3 2017 Results - Conference call Wednesday 25 October at 9:00 CET
09/10/2017
This is a correction of the announcement from 16:15 09.10.2017 GMT. Reason for the correction: Changes made to the Icelandic version. No change to the English version. Announcement from Össur hf. no: 72/2017 Conference [...]

Pages